Literature DB >> 24132591

MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.

Lei Shen1, Xiao-Dong Chen, Yao-Hui Zhang.   

Abstract

MicroRNAs are a class of small noncoding RNAs that function as critical gene regulators through targeting mRNAs for translational repression or degradation. Several studies have indicated that abnormal expression of miRNAs occurs frequently in human osteosarcoma. In the present study, we found that miR-128 expression was significantly increased in osteosarcoma tissues compared to adjacent normal tissues. Ectopic overexpression of miR-128 significantly promoted while suppression of miR-128 by its antisense inhibited the proliferation of MG63 and U2OS cells. At the molecular level, our results demonstrated that miR-128 overexpression could repress expression of PTEN by directly targeting PTEN 3'-untranslated region. Consistently, downstream AKT signaling was altered by miR-128 overexpression or knockdown. Therefore, our results suggest that miR-128 plays an important role in the proliferation of human osteosarcoma cells by directly regulation of PTEN/AKT signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132591     DOI: 10.1007/s13277-013-1274-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  CCN1: a novel target for pancreatic cancer.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-04-05       Impact factor: 5.782

2.  miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

Authors:  Gangxiong Huang; Kazumasa Nishimoto; Zhichao Zhou; Dennis Hughes; Eugenie S Kleinerman
Journal:  Cancer Res       Date:  2011-12-20       Impact factor: 12.701

3.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Authors:  Tetsuya Ueda; Stefano Volinia; Hiroshi Okumura; Masayoshi Shimizu; Cristian Taccioli; Simona Rossi; Hansjuerg Alder; Chang-gong Liu; Naohide Oue; Wataru Yasui; Kazuhiro Yoshida; Hiroki Sasaki; Sachiyo Nomura; Yasuyuki Seto; Michio Kaminishi; George A Calin; Carlo M Croce
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

Review 4.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

5.  Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.

Authors:  Adam A Sabile; Matthias J E Arlt; Roman Muff; Beata Bode; Bettina Langsam; Josefine Bertz; Thorsten Jentzsch; Gabor J Puskas; Walter Born; Bruno Fuchs
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

6.  miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.

Authors:  Cheng-Kui Cai; Guang-Yi Zhao; Li-Ying Tian; Lie Liu; Kang Yan; Yun-Lei Ma; Zhen-Wei Ji; Xiao-Xiang Li; Kang Han; Jie Gao; Xiu-Chun Qiu; Qing-Yu Fan; Tong-Tao Yang; Bao-An Ma
Journal:  Oncol Rep       Date:  2012-08-24       Impact factor: 3.906

7.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.

Authors:  C A Gebeshuber; J Martinez
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

Review 8.  The miRNAs in the pathgenesis of osteosarcoma.

Authors:  Wenqing Liang; Bo Gao; Peng Fu; Shuogui Xu; Yu Qian; Qingge Fu
Journal:  Front Biosci (Landmark Ed)       Date:  2013-01-01

9.  Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.

Authors:  Inamul Haque; Smita Mehta; Monami Majumder; Kakali Dhar; Archana De; Douglas McGregor; Peter J Van Veldhuizen; Sushanta K Banerjee; Snigdha Banerjee
Journal:  Mol Cancer       Date:  2011-01-13       Impact factor: 27.401

10.  MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

Authors:  Y-S Zheng; H Zhang; X-J Zhang; D-D Feng; X-Q Luo; C-W Zeng; K-Y Lin; H Zhou; L-H Qu; P Zhang; Y-Q Chen
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

View more
  36 in total

1.  MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.

Authors:  Fei Zhang; Wei Huang; Meixia Sheng; Tielong Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

3.  miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.

Authors:  Rui Tian; Xianbiao Xie; Ju Han; Canqiao Luo; Bicheng Yong; Huizhi Peng; Jingnan Shen; Tingsheng Peng
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.

Authors:  Yong Shang; Li-Qing Wang; Quan-Yi Guo; Tu-Long Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.

Authors:  Xiang Xia; Kundong Zhang; Guangtao Luo; Gang Cen; Jun Cao; Kejian Huang; Zhengjun Qiu
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

6.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

Review 7.  Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.

Authors:  Hui Jun Lim; Philip Crowe; Jia-Lin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-22       Impact factor: 4.553

8.  Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.

Authors:  Hongmei Xu; Jihong Zhu; Cong Hu; Hua Song; Yiyang Li
Journal:  J Physiol Biochem       Date:  2016-08-18       Impact factor: 4.158

9.  NOVA1 acts as an oncogene in osteosarcoma.

Authors:  Chengzhen Li; Ying He; Haijing Ma; Seongho Han
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

10.  MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.

Authors:  Chen Lv; Yuehan Hao; Guanjun Tu
Journal:  Tumour Biol       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.